X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
cancer (58) 58
female (52) 52
tumors (42) 42
neoplasms (39) 39
ovarian neoplasms - enzymology (33) 33
oncology (32) 32
pathology (30) 30
middle aged (29) 29
index medicus (28) 28
adult (26) 26
aged (24) 24
diagnosis (20) 20
immunohistochemistry (20) 20
ovarian neoplasms - pathology (20) 20
neoplasms, cystic, mucinous, and serous - enzymology (17) 17
ovarian cancer (17) 17
pancreatic neoplasms - enzymology (16) 16
carcinoma (15) 15
male (13) 13
biomarkers, tumor - analysis (12) 12
cells (12) 12
diseases (12) 12
expression (12) 12
krebs (12) 12
medicine (12) 12
metastasis (12) 12
aged, 80 and over (11) 11
cáncer (11) 11
medicine & public health (11) 11
neoplasms, cystic, mucinous, and serous - pathology (10) 10
carcinogenesis (9) 9
diagnosis, differential (9) 9
pancreatic neoplasms - pathology (9) 9
therapy (9) 9
aufsatzsammlung (8) 8
biomarkers, tumor - metabolism (8) 8
cell line, tumor (8) 8
cell transformation, neoplastic (8) 8
ovarian neoplasms - diagnosis (8) 8
prognosis (8) 8
surgery (8) 8
tumeurs (8) 8
animals (7) 7
biomarkers, tumor - genetics (7) 7
cancer cells (7) 7
carcinoembryonic antigen - analysis (7) 7
chemotherapy (7) 7
development and progression (7) 7
etiology (7) 7
gastroenterology & hepatology (7) 7
gene expression regulation, neoplastic (7) 7
generative organs, female (7) 7
genital neoplasms, female (7) 7
man (7) 7
neoplasm metastasis (7) 7
pancreatic neoplasms - diagnosis (7) 7
research (7) 7
survival (7) 7
treatment (7) 7
adenocarcinoma - enzymology (6) 6
disease progression (6) 6
disease-free survival (6) 6
maladies (6) 6
obstetrics & gynecology (6) 6
onkologie (6) 6
ovarian neoplasms - genetics (6) 6
ovarian neoplasms - mortality (6) 6
pancreas (6) 6
pancreatic cancer (6) 6
predictive value of tests (6) 6
sensitivity and specificity (6) 6
time factors (6) 6
tumor markers (6) 6
activation (5) 5
adolescent (5) 5
analysis (5) 5
antigens, tumor-associated, carbohydrate - analysis (5) 5
article (5) 5
carcinoembryonic antigen (5) 5
cell biology (5) 5
female genital neoplasm (5) 5
female genital neoplasms (5) 5
gene expression (5) 5
generative organs, female cancer (5) 5
genetics (5) 5
genital neoplasm, female (5) 5
gynecologic neoplasm (5) 5
gynecologic neoplasms (5) 5
immunological aspects (5) 5
immunology (5) 5
kaplan-meier estimate (5) 5
malignancy (5) 5
matrix metalloproteinase (5) 5
medical oncology (5) 5
mutation (5) 5
neoplasm, female genital (5) 5
neoplasm, gynecologic (5) 5
neoplasms, cystic, mucinous, and serous - genetics (5) 5
neoplasms, cystic, mucinous, and serous - mortality (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Faculty of Information - Subject Analysis Systems (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | LIPOSOMAL DOXORUBICIN | MULTICENTER | INHIBITION | SOLID TUMORS | CISPLATIN | ONCOLOGY | POLYMERASE | OPEN-LABEL | COMBINATION | CARCINOMA | MAINTENANCE THERAPY | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2018, Volume 154, Issue 5, pp. 1509 - 1523.e5
Intraductal papillary mucinous neoplasias (IPMNs) are precancerous cystic lesions that can develop into pancreatic ductal adenocarcinomas (PDACs). These large... 
Gastric | Oncocytic | Pancreatic Cancer | PanIN | TRANSFORMATION | ADENOCARCINOMA | IPMN | CANCER DEVELOPMENT | GENE | BIOLOGY | TUMOR-SUPPRESSOR | MUTATIONS | GASTROENTEROLOGY & HEPATOLOGY | PROGRESSION | Cell Proliferation | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Gene Expression Regulation, Neoplastic | Pancreatic Ducts - pathology | Carcinoma, Pancreatic Ductal - genetics | Neoplasms, Cystic, Mucinous, and Serous - genetics | Pancreatic Ducts - enzymology | Time Factors | Cell Transformation, Neoplastic - genetics | Proto-Oncogene Proteins p21(ras) - metabolism | PTEN Phosphohydrolase - genetics | Genetic Predisposition to Disease | PTEN Phosphohydrolase - deficiency | Neoplasms, Cystic, Mucinous, and Serous - pathology | Signal Transduction | Neoplasm Invasiveness | Mice, Inbred C57BL | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - enzymology | Neoplasms, Cystic, Mucinous, and Serous - enzymology | PTEN Phosphohydrolase - metabolism | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - pathology | Cell Transformation, Neoplastic - metabolism | Disease Progression | Mice, Knockout | Carcinoma, Pancreatic Ductal - enzymology | Gene Expression Regulation, Enzymologic | Cell Lineage | Phenotype | Animals | Mutation | Cell Transformation, Neoplastic - pathology | Cell Movement | Immunohistochemistry | Phosphatases | Pancreatic cancer | Medical imaging equipment | oncocytic | pancreatic cancer | gastric
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 07/2014, Volume 233, Issue 3, pp. 308 - 318
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2016, Volume 22, Issue 4, pp. 935 - 947
Journal Article
Journal Article
Human Pathology, ISSN 0046-8177, 04/2017, Volume 62, pp. 115 - 121
Journal Article
Human Pathology, ISSN 0046-8177, 2017, Volume 64, pp. 98 - 105
Summary The aim of this study was to compare the protein overexpression and gene copy number (GCN) of c-MET in ovarian carcinoma and to assess their prognostic... 
Pathology | Gene copy number | c-MET | Ovarian carcinoma | In situ hybridization | Survival | ADENOCARCINOMA | RECEPTOR | HYBRIDIZATION | PATHOLOGY | CELL LUNG-CANCER | OVEREXPRESSION | AMPLIFICATION | GASTRIC-CANCER | PATHWAY | PROTEIN EXPRESSION | EPITHELIAL OVARIAN | Immunohistochemistry | Predictive Value of Tests | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Carcinoma, Endometrioid - therapy | Neoplasms, Cystic, Mucinous, and Serous - genetics | Ovarian Neoplasms - genetics | Neoplasm Grading | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Republic of Korea | Carcinoma, Endometrioid - genetics | Neoplasms, Cystic, Mucinous, and Serous - pathology | Carcinoma, Endometrioid - enzymology | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Neoplasms, Cystic, Mucinous, and Serous - enzymology | In Situ Hybridization, Fluorescence | Gene Dosage | Chromosomes, Human, Pair 7 | Ovarian Neoplasms - enzymology | Proto-Oncogene Proteins c-met - genetics | Gene Expression Regulation, Enzymologic | Disease-Free Survival | Gene Amplification | Neoplasms, Cystic, Mucinous, and Serous - therapy | Proto-Oncogene Proteins c-met - analysis | Ovarian Neoplasms - therapy | Aged | Biomarkers, Tumor - genetics | Carcinoma, Endometrioid - pathology | Carcinoma | Patient outcomes | Genes | Genetic research | Development and progression | Ovarian cancer | Cancer | Medical colleges | Metastasis | Proteins | Genetics | Kinases | Mortality | Tumors
Journal Article
Oncology Reports, ISSN 1021-335X, 3/2014, Volume 31, Issue 3, pp. 1334 - 1342
Journal Article
Translational Research, ISSN 1931-5244, 2015, Volume 166, Issue 4, pp. 344 - 354
Journal Article
Journal of ovarian research, ISSN 1757-2215, 2014, Volume 7, Issue 1, pp. 109 - 109
Journal Article